KEY CRITERIA FOR DETERMINING WHEN AN IND DRUG CAN BE WIDELY DISTRIBUTED AND/OR SOLD UNDER FDA's "REPROPOSAL" OF TREATMENT USE AND SALE REGS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".